Galen Partners V, L.P. (Galen), Radius Venture Partners III, LLC (Radius) and certain of their affiliates completed an underwritten offering of 3,795,000 shares of Tactile Systems Technology Inc. (Tactile Medical) common stock, with our capital markets team advising Tactile Medical and Radius on the transaction.
William Blair & Company, LLC and Piper Jaffray & Co. acted as joint book-running managers, and Guggenheim Securities, LLC acted as joint passive bookrunner in the offering. Canaccord Genuity Inc. acted as co-manager. The common stock trades on the Nasdaq Global Market under the symbol "TCMD." The transaction closed on September 15, 2017.
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency, advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.
